Global Medical REIT (GMRE) | Financial Analysis & Statements
Global Medical REIT Inc. Small-cap Real Estate
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
38.2M
Gross Profit
29.6M
77.48%
Operating Income
9.2M
24.02%
Net Income
-6.1M
-16.10%
EPS (Diluted)
$-0.55
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
712.4M
Shareholders Equity
530.1M
Debt to Equity
1.34
Cash Flow Metrics
Operating Cash Flow
14.0M
Free Cash Flow
18.3M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Global Medical REIT Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 147.7M | 138.4M | 140.9M | 137.2M | 115.8M |
| Cost of Goods Sold | 32.6M | 29.3M | 28.1M | 25.2M | 15.5M |
| Gross Profit | 115.1M | 109.2M | 112.9M | 112.0M | 100.3M |
| Gross Margin % | 77.9% | 78.9% | 80.1% | 81.6% | 86.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 20.0M | 21.1M | 16.9M | 16.5M | 16.5M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 20.0M | 21.1M | 16.9M | 16.5M | 16.5M |
| Operating Income | 36.0M | 32.7M | 37.9M | 38.7M | 37.0M |
| Operating Margin % | 24.4% | 23.6% | 26.9% | 28.2% | 31.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 31.8M | 28.7M | 30.9M | 25.2M | 19.7M |
| Other Non-Operating Income | -11.2M | 2.7M | 14.8M | 6.5M | 1.0M |
| Pre-tax Income | -6.9M | 6.7M | 21.7M | 20.0M | 18.3M |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -6.9M | 6.7M | 21.7M | 20.0M | 18.3M |
| Net Margin % | -4.7% | 4.8% | 15.4% | 14.6% | 15.8% |
| Key Metrics | |||||
| EBITDA | 95.4M | 89.1M | 97.0M | 96.5M | 84.4M |
| EPS (Basic) | - | $0.05 | $0.23 | $0.20 | $0.19 |
| EPS (Diluted) | - | $0.05 | $0.23 | $0.20 | $0.19 |
| Basic Shares Outstanding | - | 13187200 | 65550000 | 65462000 | 60640000 |
| Diluted Shares Outstanding | - | 13187200 | 65550000 | 65462000 | 60640000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Global Medical REIT Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 9.1M | 6.8M | 1.3M | 4.0M | 7.2M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 7.2M | 7.4M | 6.8M | 8.0M | 6.1M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 19.8M | 17.3M | 14.4M | 30.5M | 24.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 13.1M | 7.3M | 7.6M | 3.5M | 3.8M |
| Goodwill | 58.1M | 65.9M | 77.8M | 103.1M | 99.7M |
| Intangible Assets | 46.3M | 54.1M | 66.0M | 91.3M | 87.9M |
| Long-term Investments | 6.1M | 18.6M | 25.1M | 34.7M | 1.2M |
| Other Non-Current Assets | 36.7M | 34.7M | 30.0M | 31.2M | 25.7M |
| Total Non-Current Assets | 1.2B | 1.2B | 1.3B | 1.4B | 1.2B |
| Total Assets | 1.2B | 1.3B | 1.3B | 1.4B | 1.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 18.3M | 16.5M | 12.8M | 13.8M | 10.3M |
| Short-term Debt | 652.7M | 631.7M | 585.3M | 636.4M | 514.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 689.4M | 671.4M | 619.3M | 670.5M | 540.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 14.6M | 25.8M | 33.6M | 60.6M | 57.2M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 8.4M | 3.3M | 9.0M | 13.1M | 20.4M |
| Total Non-Current Liabilities | 23.0M | 29.1M | 42.5M | 73.7M | 85.3M |
| Total Liabilities | 712.4M | 700.6M | 661.9M | 744.2M | 625.9M |
| Equity | |||||
| Common Stock | 13.0K | 67.0K | 66.0K | 66.0K | 65.0K |
| Retained Earnings | -350.0M | -293.7M | -239.0M | -198.7M | -157.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 530.1M | 555.9M | 605.8M | 649.1M | 637.6M |
| Key Metrics | |||||
| Total Debt | 667.3M | 657.5M | 618.9M | 697.0M | 571.7M |
| Working Capital | -669.6M | -654.1M | -605.0M | -640.0M | -515.6M |
Balance Sheet Composition
Global Medical REIT Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -6.9M | 6.7M | 21.7M | 20.0M | 18.3M |
| Depreciation & Amortization | 58.7M | 56.1M | 59.0M | 57.7M | 47.3M |
| Stock-Based Compensation | 4.5M | 5.1M | 4.2M | 4.7M | 5.8M |
| Working Capital Changes | -943.0K | -1.4M | -3.9M | -2.7M | -4.0M |
| Operating Cash Flow | 58.6M | 69.1M | 84.1M | 82.4M | 69.7M |
| Investing Activities | |||||
| Capital Expenditures | -70.5M | -81.7M | -442.0K | -150.9M | -192.3M |
| Acquisitions | 0 | -2.1M | - | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -72.3M | -89.9M | -1.7M | -149.9M | -190.7M |
| Financing Activities | |||||
| Share Repurchases | -6.0M | - | - | - | - |
| Dividends Paid | -58.1M | -65.7M | -64.8M | -64.2M | -58.3M |
| Debt Issuance | 138.3M | 143.8M | - | 0 | 221.6M |
| Debt Repayment | -125.0M | -111.1M | -169.2M | -16.7M | -232.2M |
| Financing Cash Flow | -10.3M | -21.9M | -280.2M | 46.9M | 125.1M |
| Free Cash Flow | -8.1M | -25.1M | 58.4M | -79.7M | -132.7M |
| Net Change in Cash | -23.9M | -42.7M | -197.8M | -20.6M | 4.0M |
Cash Flow Trend
Global Medical REIT Key Financial Ratios
Valuation Ratios
Forward P/E
299.83
Price to Book
1.18
Price to Sales
6.77
PEG Ratio
299.83
Profitability Ratios
Profit Margin
1.73%
Operating Margin
24.48%
Return on Equity
0.41%
Return on Assets
1.70%
Financial Health
Current Ratio
1.91
Debt to Equity
142.96
Beta
1.20
Per Share Data
EPS (TTM)
$-0.26
Book Value per Share
$30.61
Revenue per Share
$10.83
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GMRE | 956.6M | - | 1.18 | 0.41% | 1.73% | 142.96 |
| Welltower | 147.1B | 146.65 | 3.44 | 2.54% | 8.64% | 49.49 |
| Ventas | 39.8B | 153.57 | 3.14 | 2.17% | 4.32% | 102.00 |
| LTC Properties | 1.9B | 15.36 | 1.97 | 11.18% | 45.79% | 85.30 |
| Diversified | 1.8B | -6.26 | 1.08 | -15.78% | -18.59% | 145.16 |
| Sila Realty Trust | 1.7B | 50.67 | 1.25 | 2.42% | 16.77% | 54.02 |
Financial data is updated regularly. All figures are in the company's reporting currency.






